PURE Bioscience (OTCMKTS:PURE) Shares Pass Above 200 Day Moving Average – Time to Sell?

PURE Bioscience (OTCMKTS:PURE)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.06 and traded as high as $0.06. PURE Bioscience shares last traded at $0.0591, with a volume of 161,093 shares changing hands.

PURE Bioscience Stock Up 3.7%

The company has a 50 day moving average price of $0.05 and a 200-day moving average price of $0.06. The company has a market cap of $6.61 million, a P/E ratio of -1.97 and a beta of 0.52.

About PURE Bioscience

PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.

PURE’s product suite includes concentrate formulations and ready-to-use solutions.